Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-01-25 @ 1:04 AM
Study NCT ID:
NCT02861534
Status:
COMPLETED
Last Update Posted:
2021-11-15
First Post:
2016-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-05
First Submit QC Date:
None
Study First Post Date:
2016-08-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-11
Results First Submit QC Date:
None
Results First Post Date:
2020-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-12
Last Update Post Date:
2021-11-15
Last Update Post Date Type:
ACTUAL